Key Takeaways
- Market share under pressure, but fixed income a bright spot: Equity market share declined as growth-style funds lagged a value-tilted market, while fixed income and hybrid categories gained ground. Management is repositioning five or six equity schemes to recapture share.
- Yield compression across categories, driven by mix and regulation: Overall yield fell ~2 bps QoQ, with ETF yields halving to 4 bps on EPFO fee cuts and income fund yields dropping 4 bps as inflows concentrated in shorter-duration, lower-fee products.
- Distribution push underway, costs contained: 29 new offices opened, taking total UTI Financial Centres to 195, with 134 in B30 locations. Consolidated employee cost growth guided at 4–5% for the year.
- International business building, but costs are coming: SEBI approval received for US operations; Paris office opened. Major establishment costs hit only in Q1 next fiscal, so near-term P&L impact is limited.
- What to watch next quarter: Whether repositioned equity schemes start stemming market share loss, the pace of fixed-income market share gains, and any further yield compression if stock AUM redemption accelerates.
Market Share & Fund Performance
- Equity market share declined as growth-oriented funds underperformed when the market rotated toward value. Management acknowledged the drag and said course correction is underway across five or six schemes, including Hybrid Equity, Core Equity, and Equity Saving Fund.
- Fixed income and hybrid gained share on both quarterly average and closing average bases. Cash and arbitrage, a seasonal product, also saw market share improvement.
- SIP count fell marginally because UTI discloses only live SIPs, not paused ones. Some paused SIPs were not restarted due to distributor issues; management said the number would look better if paused SIPs were included.
- Equity net outflows were channel-agnostic, though banking channels may have seen higher churn. Management is positioning flanking products to win back equity share.
Sandeep Samsi: "We don't want to show all SIPs. We only want to showcase our live SIPs and so that number has come down."
Yield Dynamics
- Equity yields stabilized at 72–73 bps, flat QoQ. Earlier quarters saw yield pressure when redeemed stock AUM was replenished by fresh inflows; that dynamic was absent this quarter but flagged as a forward risk.
- ETF yields compressed sharply from 7 bps to 4 bps after UTI submitted a revised EPFO bid. Competitors quoted expense ratios even lower than 4 bps, forcing fee reductions of 2–3 bps. UTI's EPFO yields remain the best in the industry, per management.
- Income fund yields fell from 26 bps to 22 bps as significant inflows went into shorter-duration products carrying lower management fees.
- Hybrid fund yields dipped from 90 bps to 84 bps due to the UTI Balanced Advantage Fund NFO, which mobilized at a lower yield of ~30–35 bps. NFO yields across equity and hybrid categories have been structurally lower than ongoing scheme yields for several years.
- International business saw no yield compression, only a marginal AUM decline from IDEF redemptions that reduced management fees.
Imtaiyazur Rahman: "In EPFO our yields are best in industry."
Distribution Expansion & Cost Management
- Physical footprint grew aggressively: 29 new UTI Financial Centres inaugurated on 29 September 2023, bringing the total to 195, of which 134 are in B30 locations. Management plans to open 8–10 more resident offices.
- Employee additions concentrated in distribution, including management trainees hired from campus to build a bench as senior staff retire. UTI also plans to expand its direct channel.
- Consolidated employee cost growth guided at 4–5% for the full year; standalone UTI AMC salary increase capped at 2–3%. Q2 saw a normal wage hike, ~₹2 crore in additional ESOP amortization, and an actuarial valuation increase.
- Digital infrastructure refreshed: mobile apps for investors and distribution partners relaunched with better UI, and contact centre technology upgraded.
Product Pipeline & Regulatory Developments
- Four NFOs launched in H1 FY24: UTI Nifty50 Equal Weight Index Fund, UTI S&P BSE Housing Index Fund, UTI Balanced Advantage Fund, and UTI Innovation Fund.
- Alternatives platform expanding: SEBI approval received for UTI Credit Opportunities Fund I and UTI Asset Reconstruction Opportunities Fund I, plus approval to offer Co-Investor Portfolio Manager services. Seven co-investor clients onboarded by September 30, 2023.
- Three ETF approvals in hand: UTI Nifty IT ETF, UTI Nifty 10-year benchmark G-Sec ETF, and UTI 5-year benchmark G-Sec ETF. Launches will be timed to market opportunity.
- Passive product pipeline is mostly passive-side: no active equity schemes planned for launch in the near term.
- EPFO mandate renewed: UTI was one of four selected managers (alongside SBI, ICICI, and Nippon) with a ~23.5% share. UTI's fee is the highest among the four.
International Business
- US operations approved by SEBI: license expected by March 2024, so no material cost this fiscal year. Major expenses, including hiring and establishment costs, will land in Q1 FY25. Other legal expenses are ~₹1 crore.
- Paris office opened: footprint now extends across Europe, Asia, and Australia. Management is focused on growing international volume.
- Seed investments in international funds have not been reduced in the last six months. Management is waiting for sales momentum in IDEF, the flagship scheme, before further reducing seed capital.
Margin & Regulatory Outlook
- TER reduction would protect AMC margins: management stated that any future TER cut would be passed through to intermediaries, with AMC margins protected. Volume growth would then drive absolute revenue improvement. PAT margin is expected to improve from current levels.
- Passive fund operating leverage: OpEx for passive products is not expected to rise; only volume will increase, so absolute yield should be superior for the industry.
- Commission structure on NFOs carries a slightly higher first-year payout, with trail commissions stepping down from year two onward. SEBI caps total commission at the distributable expense ratio.
Vinay Lakhotia: "I think industry thought process, I can say very clear if any TER reduction come that will be passed on to the intermediaries. AMC margin, I think most of the AMC will try to protect the margin and the TER cut will be passed on the long term."
Imtaiyazur Rahman: "Regulation is not there to harm the investor. We should not see from the regulation perspective. We should look at the opportunity perspective and I believe the tremendous opportunity for the entire industry to grow."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Consolidated employee cost growth | Not more than 4–5% vs previous year | FY24 full year |
| Standalone AMC salary increase | Not more than 2–3% | FY24 full year |
| US operations major expenses | Hiring and establishment costs begin | Q1 FY25 |
| Equity market share recovery | Repositioning 5–6 equity schemes; detailed strategy in place | Not specified (course correction underway) |
| Fixed income market share | Expected to improve | Next few quarters |
| PAT margin | Should improve from here onwards | Not specified |
| New ETF launches | UTI Nifty IT ETF, Nifty 10-year G-Sec ETF, 5-year G-Sec ETF | As and when opportune |
| Alternatives fund launches | UTI Credit Opportunities Fund I, UTI Asset Reconstruction Opportunities Fund I | Soon |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Consolidated revenue from operations | ₹404 crore |
| Consolidated net profit | ₹183 crore |
| Standalone PAT | ₹134 crore, growth of 14% YoY |
| Standalone PAT H1 FY24 | ₹299 crore, higher by 38% YoY |
| Consolidated revenue from operations H1 FY24 | ₹872 crore, up by 27% YoY |
| Consolidated net profit H1 FY24 | ₹417 crore, higher by 43% YoY |
| Total AUM for UTI Group | ₹16.89 lakh crore, growth of ~16.89% YoY |
| Domestic mutual fund QAAUM | ₹2.67 lakh crore, growth of ~14.22% YoY |
| Equity QAAUM | ₹78,291 crore, rising ~9.2% YoY |
| QAAUM for Index & ETFs | ₹98,421 crore, growth of ~35.82% YoY |
| Market share of gross sales | 7.8% |
| Equity market share decline | ~22 bps QoQ and 75 bps YoY |
| SIP AUM | ₹26,541 crore, growth of 29% YoY |
| SIP inflows for Q2 | ₹1,648 crore |
| Average SIP ticket size | ₹3,140 for September 2023 |
| B30 cities contribution to Monthly Average AUM | 23%, industry average 17% |
| Live folios | 1.22 crore, added 1.03 lakh folios |
| Equity fund yield (stock AUM) | ~72 basis points, down from ~80 bps a year ago |
| Hybrid fund yield | 84 basis points, down from 90 bps |
| ETFs and Index Fund yield | 4 basis points, down ~3 bps QoQ due to revised EPFO bid |
| Income fund yield | 22 basis points, down from 26 bps |
| Overall yield compression | ~2 basis points lower |
| UTI Retirement Solutions AUM | ~₹2.7 lakh crore, growth of ~24% YoY; manages 26.4% of NPS AUM |
| UTI International AUM | ₹24,207 crore |
| UTI Alternatives total AUM | ₹1,799 crore |
| Seed capital in international funds | USD 18 million |
| EPFO incremental flow share | 23.5%, highest fee among the four selected AMCs |
| Gross equity sales for Q2 | ~₹2,000 crore |
| Employee cost increase on standalone basis | ₹6-7 crore QoQ |
| Salary cost growth guidance (consolidated) | 4 to 5% YoY |
| Effective tax rate guidance for the year | 20 to 21% |